These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672 [TBL] [Abstract][Full Text] [Related]
26. Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology. Sands M; McCarter Y; Sanchez W Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):521-2. PubMed ID: 17558487 [No Abstract] [Full Text] [Related]
27. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity. Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347 [TBL] [Abstract][Full Text] [Related]
28. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
29. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii. Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797 [TBL] [Abstract][Full Text] [Related]
30. In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods. Tan TY; Lim TP; Lee WH; Sasikala S; Hsu LY; Kwa AL Antimicrob Agents Chemother; 2011 Jan; 55(1):436-8. PubMed ID: 20956606 [TBL] [Abstract][Full Text] [Related]
31. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B. Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109 [TBL] [Abstract][Full Text] [Related]
32. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii. Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200 [TBL] [Abstract][Full Text] [Related]
33. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii. Wang Y; Li X; Wang D; Sun S; Lu C Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159 [TBL] [Abstract][Full Text] [Related]
34. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963 [TBL] [Abstract][Full Text] [Related]
35. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia. Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806 [TBL] [Abstract][Full Text] [Related]
36. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data. Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741 [TBL] [Abstract][Full Text] [Related]
37. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166 [TBL] [Abstract][Full Text] [Related]
38. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy. Moland ES; Craft DW; Hong SG; Kim SY; Hachmeister L; Sayed SD; Thomson KS Antimicrob Agents Chemother; 2008 Aug; 52(8):2940-2. PubMed ID: 18519722 [TBL] [Abstract][Full Text] [Related]
39. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii. Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956 [TBL] [Abstract][Full Text] [Related]
40. Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals. Falagas ME; Skalidis T; Vardakas KZ; Voulgaris GL; Papanikolaou G; Legakis N; Int J Antimicrob Agents; 2018 Aug; 52(2):269-271. PubMed ID: 29559273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]